A multi-cycle open label study of nebulized liposomal amikacin (Arikace™) in the treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection
P. Minic, S. Fustic, E. Solyom, H. Mazurek, Y. Antipkin, A. Feketova, A. Senatorova, E. Csiszer, V. Kostromina, B. Takac, R. Ujhelyi, R. GuptaVolume:
9
Year:
2010
Language:
english
DOI:
10.1016/s1569-1993(10)60237-8
File:
PDF, 53 KB
english, 2010